333 related articles for article (PubMed ID: 1897380)
1. Levels of serum steroid hormones in intrauterine contraceptive device users.
Fahmy K; el-Gazar A; Eisa I; Ghonaim M; Saad S; Afifi A
Gynecol Endocrinol; 1991 Mar; 5(1):1-5. PubMed ID: 1897380
[TBL] [Abstract][Full Text] [Related]
2. Serum and endometrial sodium and potassium levels with inert and copper-containing IUCDs and relation to serum steroid levels.
Fahmy K; Ghoneim M; Eisa I; el-Gazar A; Afifi A
Contraception; 1992 Jun; 45(6):573-81. PubMed ID: 1617966
[TBL] [Abstract][Full Text] [Related]
3. Serum and endometrial copper, zinc, iron and cobalt with inert and copper-containing IUCDs.
Fahmy K; Ghoneim M; Eisa I; el-Gazar A; Afifi A
Contraception; 1993 May; 47(5):483-90. PubMed ID: 8513675
[TBL] [Abstract][Full Text] [Related]
4. Hormonal profile in IUD users.
Souka AR; Rahman H; Osman M; Mohei Y; Rizk M
Contracept Deliv Syst; 1981 Oct; 2(4):303-10. PubMed ID: 12336991
[TBL] [Abstract][Full Text] [Related]
5. The menstrual cycle in women using an intrauterine device.
Faundes A; Segal SJ; Adejuwon CA; Brache V; Leon P; Alvarez-Sanchez F
Fertil Steril; 1980 Nov; 34(5):427-30. PubMed ID: 7439408
[TBL] [Abstract][Full Text] [Related]
6. Effect of levonorgestrel-releasing intrauterine device on hormonal profile and menstrual pattern after long-term use.
Xiao B; Zeng T; Wu S; Sun H; Xiao N
Contraception; 1995 Jun; 51(6):359-65. PubMed ID: 7554977
[TBL] [Abstract][Full Text] [Related]
7. Serum ovarian steroids, prolactin and prostaglandin metabolites in women using the inert intrauterine device.
Shalev E; Harpaz-Kerpel S; Engelhard Y; Weiner E; Eran A; Zuckerman H
Int J Gynaecol Obstet; 1987 Apr; 25(2):139-44. PubMed ID: 2884139
[TBL] [Abstract][Full Text] [Related]
8. Chlamydial serologic characteristics among intrauterine contraceptive device users: does copper inhibit chlamydial infection in the female genital tract?
Mehanna MT; Rizk MA; Ramadan M; Schachter J
Am J Obstet Gynecol; 1994 Sep; 171(3):691-3. PubMed ID: 8092216
[TBL] [Abstract][Full Text] [Related]
9. Corpus luteum function in medicated and non-medicated IUD users.
Abdalla MI; Ibrahim II; Osman MI; Bayad MA; Hafez ES
Contracept Deliv Syst; 1983 Jul; 4(3):163-7. PubMed ID: 12265358
[TBL] [Abstract][Full Text] [Related]
10. Sonographic assessment of ovarian and endometrial changes during long-term Norplant use and their correlation with hormonal levels.
Shaaban MM; Segal S; Salem HT; Ghaneimah SA; Khalifa EA; Ahmed AG
Fertil Steril; 1993 May; 59(5):998-1002. PubMed ID: 8486202
[TBL] [Abstract][Full Text] [Related]
11. Progesterone and estradiol patterns in women using an intrauterine contraceptive device.
Brenner PF; Mishell DR
Obstet Gynecol; 1975 Oct; 46(4):456-9. PubMed ID: 1165881
[TBL] [Abstract][Full Text] [Related]
12. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
[TBL] [Abstract][Full Text] [Related]
13. Absence of chorionic gonadotropin in sera of women who use intrauterine devices.
Segal SJ; Alvarez-Sanchez F; Adejuwon CA; Brache de Mejia V; Leon P; Faundes A
Fertil Steril; 1985 Aug; 44(2):214-8. PubMed ID: 4018277
[TBL] [Abstract][Full Text] [Related]
14. The role of the levonorgestrel intrauterine device in the prevention and treatment of iron deficiency anemia during fertility regulation.
Faundes A; Alvarez F; Brache V; Tejada AS
Int J Gynaecol Obstet; 1988 Jun; 26(3):429-33. PubMed ID: 2900174
[TBL] [Abstract][Full Text] [Related]
15. Vaginal pH effects caused by OCs and various copper and inert IUDs.
Kandil O; Hassanein MK; El-tagi A; El-shirbini MT
Contracept Deliv Syst; 1983 Jul; 4(3):187-93. PubMed ID: 12265361
[TBL] [Abstract][Full Text] [Related]
16. Effects of various IUDs on the composition of cervical mucus.
Jonsson B; Landgren BM; Eneroth P
Contraception; 1991 May; 43(5):447-58. PubMed ID: 1914458
[TBL] [Abstract][Full Text] [Related]
17. Onapristone (ZK 98.299): a potential antiprogestin for endometrial contraception.
Katkam RR; Gopalkrishnan K; Chwalisz K; Schillinger E; Puri CP
Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):779-87. PubMed ID: 7573244
[TBL] [Abstract][Full Text] [Related]
18. Hormonal and menstrual changes after laparoscopic sterilization by Falope-rings or Filshie-clips.
Thranov I; Hertz JB; Kjer JJ; Andresen A; Micic S; Nielsen J; Hancke S
Fertil Steril; 1992 Apr; 57(4):751-5. PubMed ID: 1532561
[TBL] [Abstract][Full Text] [Related]
19. The sequence of pituitary responses to synthetic luteinizing hormone releasing hormone (LH-RH) throughout the normal menstrual cycle.
Grimes EM; Thompson IE; Taymor ML
Acta Endocrinol (Copenh); 1975 Aug; 79(4):625-34. PubMed ID: 1098349
[TBL] [Abstract][Full Text] [Related]
20. Clinical performance of the TCu 380A and Lippes Loop IUDs in three developing countries.
Farr G; Amatya R; Acosta M; Ekwempu C; Kisninci H
Contraception; 1995 Jul; 52(1):17-22. PubMed ID: 8521710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
